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An 88-year-old man with respiratory symptoms was found to have

CD30, CD3, CD4, CD5, CD2, MUM1, and negativity for ALK1, CD7,

prominent lymphadenopathy in the chest, ill-defined low-density

CD8, TIA-1, granzyme B, CD20, and PAX5. This was consistent with

lesions in the liver (Figure 1A), and diffuse abdominal lymphade-

a diagnosis of ALK-negative anaplastic large cell lymphoma (ALK-

nopathy. A biopsy of the liver lesion revealed sheets of anaplastic

negative ALCL). Fluorescence in situ hybridization (FISH) studies

cells with several cells demonstrating eosinophilic pseudo-nuclear

detected positive DUSP22 (IRF4) rearrangement and no TP63 re-

inclusions (“doughnut cells”) (Figure 1B, upper right inset),

arrangement. Subsequently, elevated serum uric acid (13 mg/dL)

horseshoe-shaped nuclei (“hallmark cells”) (Figure 1B, lower left

and lactate dehydrogenase (LDH) levels (1018 IU/L) were detected

inset), and occasional cells with multinucleation (Figure 1B, lower

leading to suspicion of tumor lysis syndrome, which prompted al-

right inset). Immunohistochemistry demonstrated positivity for

lopurinol and rasburicase therapies. Following this, the patient's

FIGURE 1 A, CT scan abdomen
demonstrating multiple ill-defined low-
density lesions with the largest measuring
3 cm (arrow). B, Hematoxylin and eosin (H&E
×500)-stained section from liver biopsy
demonstrating sheets of anaplastic cells
with occasional “doughnut” cell morphology
(arrow and upper right inset), hallmark
cells (lower left inset), and multinucleated
cells (lower right inset). C, Post-rasburicase
peripheral smear demonstrating blister
cells (arrow), schistocytes (arrow-head),
fragmented RBCs, and atypical ALCL
lymphocytes. D, Flow cytometry of
peripheral blood demonstrating CD3+
(dim), CD4+ ALCL lymphocytes (circled
population)
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hemoglobin dropped to 5.8 g/dL and laboratory workup showed

bodies as exhibited by supravital stains. However, diagnosis is best

low haptoglobin (<30.0 mg/dL), increased total bilirubin (3.2 mg/

established by a quantitative G6PD test. 3 A caveat is that false nor-

dL), and elevated D-dimer level (2.4 µg/mL FEU). Peripheral blood

mal results can occur during or immediately after hemolysis (due to

smear demonstrated blister cells, schistocytes, fragmented RBCs,

reticulocytosis) requiring a repeat analysis. In patients with tumor

and atypical lymphocytes (18%) with absolute lymphocyte count

lysis syndrome, G6PD deficiency should be ruled out prior to ras-

of 3 K/µL (Figure 1C). Peripheral blood flow cytometry revealed

buricase therapy. 3

the presence of an atypical CD3+ (dim), CD4+ T-cell population
(Figure 1D) (also positive for CD2, CD5, CD25 (dim, subset), T-cell

C O N FL I C T O F I N T E R E S T

receptor alpha/beta, and negative for CD8, CD7, CD26, CD56,
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CD16, CD57, and T-cell receptor gamma/delta) supportive of ALCL
in leukemic phase. The presence of hemolysis raised the suspicion
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for glucose-6 -phosphate dehydrogenase (G6PD) deficiency. G6PD

Data available on request from the authors

quantification confirmed low levels; 4.0 U/g Hgb (normal range,
7.0-20.5 U/g Hgb). Rasburicase was discontinued; patient was

ORCID

given blood transfusions and hemolysis resolved.
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ALK-negative ALCL is an uncommon variant of mature T-cell
lymphomas that comprises 40%-50% of systemic ALCL.1 It affects
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ALK-p ositive ALCL, which occurs mostly in children/young adults
and responds well to chemotherapy.1 Peripheral blood involvement is rare, and most reported cases are ALK-p ositive ALCL in
children. In a series of four adult patients with ALK-negative ALCL
in leukemic phase, both survival and response to therapy were
poor. 2 DUSP22 rearrangement (30% of ALK-negative ALCLs) is associated with a good prognosis and "doughnut cell-" like morphology.1 This patient was also discovered to have G6PD deficiency
which is most commonly caused by mutations of the G6PD gene
(x-linked). 3 In these patients, oxidative hemolysis can be triggered
by ingestion of fava beans, infections, and a myriad of drugs (antibiotics, antimalarials, rasburicase, pegloticase, etc). 3 Peripheral
smear generally demonstrates the presence of blister cells, bite
cells, schistocytes, and polychromasia. RBCs can also exhibit Heinz
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